Bavarian Nordic AS (CHIX:BAVAC) Other Stockholders Equity: kr287 Mil (As of Mar. 2026)


CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
84 GF Score
Price kr188.30
GF Value kr161.93
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Other Stockholders Equity?

Bavarian Nordic AS CHIX:BAVAC 84 Other Stockholders Equity is kr287 Mil as of Mar. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 84/100 and a GF Value™ of kr161.93 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Bavarian Nordic AS's Other Stockholders Equity for the quarter that ended in Mar. 2026 was kr287 Mil.

Bavarian Nordic AS's quarterly Other Stockholders Equity declined from Sep. 2025 (kr308 Mil) to Dec. 2025 (kr270 Mil) but then increased from Dec. 2025 (kr270 Mil) to Mar. 2026 (kr287 Mil).

Bavarian Nordic AS's annual Other Stockholders Equity declined from Dec. 2023 (kr230 Mil) to Dec. 2024 (kr189 Mil) but then increased from Dec. 2024 (kr189 Mil) to Dec. 2025 (kr270 Mil).

Bavarian Nordic AS Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS Other Stockholders Equity Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.19 143.52 230.49 188.66 269.98

Bavarian Nordic AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 262.33 385.92 308.43 269.98 287.12
CHIX:BAVAC
84GF Score
Bavarian Nordic AS CHIX:BAVAC
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of kr287 Mil mean?
Bavarian Nordic AS (CHIX:BAVAC) has a Other Stockholders Equity of kr287 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's Other Stockholders Equity too high?
Bavarian Nordic AS's current Other Stockholders Equity is kr287 Mil. Overall, Bavarian Nordic AS has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Other Stockholders Equity compare to VRTX and REGN?
Bavarian Nordic AS's Other Stockholders Equity of kr287 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current Other Stockholders Equity is kr287 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr161.93, compared to a current price of kr188.30 — trading 16.3% above its estimated fair value. The current Other Stockholders Equity is kr287 Mil. Bavarian Nordic AS's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Other Stockholders Equity is kr287 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 16.3% above its estimated GF Value™ of kr161.93. GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.

Key valuation signals for CHIX:BAVAC:

  • Other Stockholders Equity: kr287 Mil
  • GF Value™: kr161.93 vs. price of kr188.30 (16.3% above fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
84GF Score

Get the complete analysis for CHIX:BAVAC

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr161.93
GF Value